The future of medicine

Our Team

View our research and commercial team

Investors

See how you can partner with us

Contact Us

Learn more about what we do

What We Do

Viro-Gen has developed an important body of research following a scientific breakthrough at a leading medical university in South Africa. The research was overseen by five PhD doctors in the fields of Virology and Biochemistry as well as Professors in Biochemistry and Chemistry.

Viro-Gen discovered a method of using a rare immune system protein to optimize human immunity against viral infection. Our work has opened the possibility of treating and preventing viral infections, cancers and other diseases by using the immune system’s own natural defences. This rare protein is present in all humans, albeit in small quantities. By optimising its concentration in the blood, Viro-Gen expects to unlock new possibilities in disease management.

The characteristics, genetic sequence and optimal concentration levels of this naturally occurring protein are now known to Viro-Gen. With this information, Viro-Gen is developing the world’s first therapeutic isotekh for viral infections and potentially other diseases.

Future Technology

 

Disease prevention in the form of vaccines focuses on training the immune system to recognise a virus. This paradigm has served humanity since 1796 when parts of the cowpox virus were used to generate an immune response against smallpox. More than 200 years later, Viro-Gen has made discovery which is a quantum leap in disease prevention and management.

Viro-Gen is using an immune system protein that the human body naturally produces to fight infection. Research has found that in cases where disease overpowers the immune system, the body’s production of this immune system protein is sub-optimal. By optimising the occurrence of this immune system protein in the human body, humanity is shifted into a new paradigm of disease control. Yesterday’s technology was based on vaccine therapeutics. Tommorow’s technology is based on isotekh therapeutics.

Future Technology

Disease prevention in the form of vaccines focuses on training the immune system to recognise a virus. This paradigm has served humanity since 1796 when parts of the cowpox virus were used to generate an immune response against smallpox. More than 200 years later, Viro-Gen has made discovery which is a quantum leap in disease prevention and management.

Viro-Gen is using an immune system protein that the human body naturally produces to fight infection. Research has found that in cases where disease overpowers the immune system, the body’s production of this immune system protein is sub-optimal. By optimising the occurrence of this immune system protein in the human body, humanity is shifted into a new paradigm of disease control. Yesterday’s technology was based on vaccine therapeutics. Tommorow’s technology is based on isotekh therapeutics.

Isotekh

 

/’iso:tek/

Noun

A substance used to optimise broad immune system activity against disease

Isotekh

 

/’iso:tek/

Noun

A substance used to optimise broad immune system activity against disease

Our Team

 

Our research work is contracted out to premier Research institutions in Africa and Brazil under the supervision of large teams of doctoral scientists. Our board of directors is comprised of multidisciplinary skills across Virology, Patent Law, Actuarial Science and Corporate Finance.

Our Team

Our research work is contracted out to premier Research institutions in Africa and Brazil under the supervision of large teams of doctoral scientists. Our board of directors is comprised of multidisciplinary skills across Virology, Patent Law, Actuarial Science and Corporate Finance.

Investment Opportunity

 

Viro-Gen offers investors an unparalleled investment opportunity in a technology that will revolutionise immunology and disease treatment across multiple disease classes.

Investment Opportunity

 

Viro-Gen offers investors an unparalleled investment opportunity in a technology that will revolutionise immunology and disease treatment across multiple disease classes.

Our Address

PMA House, Block B, Ground Floor,
Tijger Vallei Office Park, Silver Lakes Road,
Silver Lakes, Pretoria, 0081

    Contact Us

Tel No: +27 (0)87 092 5148
Email:  info@viro-gen.com